Hot Investor Mandate: VC Firm Invests Up to $30M in Medical Technology and Digital Health Sectors, Mainly Within Western Europe, But Open to Global Opportunities

20 Oct

A venture capital firm that was established in 2015 and is headquartered in Western Europe. The firm will consider pre-seed investments but is primarily looking to participate in the Seed to Series A financings of early-stage companies with typical pre-money valuation usually between USD 5 million and USD 30 million. Average ticket size is USD 0.5 million. The firm currently participates in equity investments as well as convertible debt. The firm historically has made around ten new investments per year. The firm is focused on partnering with companies based in Western Europe but will consider global opportunities.

The firm is primarily interested in investing in companies in the medical technology and digital health sectors but will also consider those in the wearables and diagnostics sector as well. The firm is open to all modalities within the medical technology and digital health sectors but prefers diagnostic companies to be focused on devices rather than genomics or in vitro diagnostics. The firm will not consider investments in biotech or pharma companies. The firm prefers to invest in pre-market technologies with some proof of pre-clinical data available and will only invest in Class I and Class II (510k) medical devices, avoiding Class III (PMA). The firm will consider companies across all disease indications but prefers to avoid complex disease indications such as the oncology space.

The firm is open to working with both inexperienced and experienced management teams. The firm looks to work with management teams that are efficient and work well together. The firm will sometimes take a board seat as determined on a case-by-case basis. The firm normally prefers to co-invest but will occasionally take a lead role in investments.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a comment